NCT05527405 · COMPLETED
Efficacy of Caregiver Training Program in Enhancing Caregiver and Patient Outcomes
Sponsor: MapHabit, Inc.
This trial is testing a tablet-based visual scheduling app called MapHabit, paired with a structured caregiver training program, to see whether the combination reduces caregiver burden and improves daily functioning for people with Alzheimer's or related dementias. It is a Phase NA randomized controlled trial — meaning it is evaluating a behavioral and digital tool, not a drug, in a real-world care setting. Fifty patient-caregiver pairs will be followed for six months.
You may qualify if
- Participating caregiver of individual with dementia must be the primary caregiver
- Care recipient must be an individual diagnosed with Alzheimer's disease or other related dementia (ADRD) in their mild to moderate stage of impairment
- Proficient in English
You're excluded if
- Participating caregiver of individual with dementia is NOT the primary caregiver
- Care/support recipient not diagnosed with ADRD
- Not proficient in English
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-06-10